Showing results (1901-1910 of 2,084) with videos related to
Sort By:
Pageof 209
Melanoma Research|August 12, 2004
Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patientsFrancisco A Cuéllar, Antonio Vilalta, Ramón Rull, et al.Molecular Plant-Microbe Interactions : MPMI|June 29, 2026
Divergent Roles of CPK28 in Immune Homeostasis Across Land PlantsRuoqi Dou, Baptiste Castel, Cailun A S Tanney, et al.Neuropathology and Applied Neurobiology|July 14, 2022
The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent casesMélanie Pagès, Marie-Anne Debily, Frédéric Fina, et al.Scientific Reports|August 29, 2019
Revisiting the genetic diversity of emerging hantaviruses circulating in Europe using a pan-viral resequencing microarrayClaudia Filippone, Guillaume Castel, Séverine Murri, et al.JCO Precision Oncology|July 21, 2022
DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse EventsMirjam de With, Gemma Brufau, Laila A van den Berg, et al.Neuroscience and Biobehavioral Reviews|September 26, 2019
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancerMarie Lange, Hélène Castel, Johan Le Fel, et al.Open Forum Infectious Diseases|April 21, 2025
Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT)Jose M Miro, Daniela Malano-Barletta, Leire Berrocal, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 23, 2015
Landscape of early clinical trials for childhood and adolescence cancer in SpainF Bautista, S Gallego, A Cañete, et al.Cancer Research|April 20, 2022
The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression RegulationErik Ladewig, Flavia Michelini, Komal Jhaveri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communicationNeal J Meropol, Kevin P Weinfurt, Caroline B Burnett, et al.Pageof 209